Pfizer (Pfizer)

Lobbying Organisation Pfizer

Date published 21 May, 2025

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2025 to 30 Apr, 2025

Specific Details Treatment of Amyloidosis and ATTR-CM M

Intended results To highlight the importance of timely access to genetic testing for those with ATTR-CM in Ireland

Name of person primarily responsible for lobbying on this activity Marc Morrison

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Pádraig O'Sullivan TD (Dáil Éireann, the Oireachtas)